CERE News and Press, Ceres Inc.

2024-07-10 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-03 12:04:34 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? Cerevel Therapeutics gains on report Tempur Sealy will be the subject of FTC meeting (update) Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie ...

2024-07-03 04:38:40 ET Summary AbbVie reported first quarter results and although results were not great, the company managed to set off declining Humira sales. Especially, Skyrizi and Rinvoq are expected to keep growing at a high pace and AbbVie made a few major acquisitions that...

2024-06-27 13:40:30 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie deal Cerevel Therapeutics seesaws amid FTC notice on closed door meeting Seeking Alpha...

2024-06-26 12:07:34 ET More on Tempur Sealy Tempur Sealy: Bedding Premiumization Offset By Headwinds In U.S. Mattress Market Tempur Sealy International, Inc. (TPX) Q1 2024 Earnings Call Transcript Tempur Sealy drops amid report of meeting with FTC on Mattress Firm; d...

2024-06-25 15:11:25 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? Cerevel Therapeutics seesaws amid FTC notice on closed door meeting Cerevel Therapeutics gains after AbbVie says making good progress with FTC Seeking Al...

2024-06-20 12:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-13 13:54:33 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? Cerevel Therapeutics gains after AbbVie says making good progress with FTC AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug ...

2024-06-12 11:30:31 ET More on Cerevel Therapeutics Cerevel Therapeutics: Time For A Risk Arbitrage Play? AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug Seeking Alpha’s Quant Rating on Cerevel Therapeutics Historical ear...

2024-06-11 00:24:03 ET Summary Baker Brothers' 13F portfolio value decreased from $8.79B to $7.97B. The largest five stakes in the portfolio are Incyte, BeiGene, ACADIA Pharma, Madrigal Pharma, and Rhythm Pharma. Baker Brothers has had successful investments in companies that ...